LexDanaLexDanabeta
Inventor

Alain Prochiantz

Inventor
Paris, FR

Overview

13→
Patents
1999–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 13 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides15%
C12NMicroorganisms or enzymes13%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
A61LMethods or apparatus for sterilising materials or objects in general4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
A61FFilters implantable into blood vessels2%
B82YSpecific uses or applications of nanostructures2%
C12YEnzymes2%
PatentTitleYear
10,842,852Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide202010,722,554Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoprotein202010,342,851Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neurons201910,100,307Use of a reverse-transcriptase inhibitor in the prevention and treatment of degenerative diseases20189,950,033Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neurons20189,868,783'Inhibition of the synthesis of beta-app or the activity of the A-β peptide in the choroid plexus'20188,575,105'Use of the engrailed homeodomain protein as anxiolytic'20138,242,088'Carrier vectors through an epithelium with tight junctions'20127,115,380'Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP)'20066,905,832'Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (APP)'20056,656,735'Method for identification of target genes of transcription factors'20036,080,724'Peptides which can be used as vectors for the intracellular addressing of active molecules'20005,888,762'Neurotropic growth factors comprising a homeobox peptide'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2020Patents assigned to CENTRE NAT RECH SCIENT (13)· patent assignee history
1999–2020Based in Paris, FR· patent location history
2012–2020Patents assigned to PROCHIANTZ ALAIN (4)· patent assignee history
2018–2019Patents assigned to COLLEGE FRANCE (4)· patent assignee history
2018Patents assigned to INST NAT SANTE RECH MED (2)· patent assignee history
2020Patents assigned to ECOLE NORMALE SUPERIEURE (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CENTRE NAT RECH SCIENT131999–2020
COLLEGE FRANCE42018–2019
PROCHIANTZ ALAINself42012–2020
ECOLE NORMALE SUPERIEURE22020
INST NAT SANTE RECH MED22018
Locations
LocationPatentsSpan
Paris, FR131999–2020